Tuya (TUYA) Announces Director Appointment

Tuya, Inc. ("Tuya" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced that the board (the "Board") of directors of the Company has appointed Ms. Zhang Yan ("Ms. Zhang") to serve as a director with immediate effect.

Ms. Zhang has been serving as the vice president of finance of the Company and several major subsidiaries since January 2021. Ms. Zhang is responsible for the finance of the Group. Prior to joining the Company, Ms. Zhang worked at Ernst & Young Hua Ming LLP from December 2009 to January 2021, where her last position was senior audit manager. Ms. Zhang received a bachelor's degree in management from Shanxi University of Finance and Economics in the PRC in July 2006, and a master's degree in management from Dongbei University of Finance and Economics in the PRC in January 2009.

As of the date of this press release, the Board comprises Mr. Wang Xueji, Mr. Chen Liaohan, Mr. Yang Yi and Ms. Zhang Yan as executive directors, and Mr. Huang Sidney Xuande, Mr. Qiu Changheng, Mr. Kuok Meng Xiong (alias Guo Mengxiong) and Mr. Yip Pak Tung Jason as independent directors. The appointment of Ms. Zhang allows the Board to meet the gender diversity requirements outlined by The Stock Exchange of Hong Kong Limited, and promotes a more balanced Board composition.

"We welcome our current vice president of finance, Ms. Zhang, to the Board as an executive director," said Mr. WANG Xueji, Founder and CEO of Tuya. "With her extensive experience in financial management and her background at the Big Four accounting firm Ernst & Young, Ms. Zhang will bring valuable expertise to the Board, aligning with Tuya's commitment of diversity."

The Board also warmly welcomes Ms. Zhang to her new role and looks forward to her continued contributions to Tuya's success.

You May Also Be Interested In

• Rent the Runway agrees to $9M settlement in IPO securities lawsuit
• MIAX Exchange Group options ADV rises 25.5% YTD through August
• H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)